Search:Please enter products name or specification to search
| NO. | Products Name | Types | Items | BP quality control specification | Chp quality control specification |
| 276 | Platycodon Root | IDENTIFICATION | Microscopic examination | powder | powder |
| Thin-layer chromatography | glucose and xylose | reference herb drug | |||
| TESTS | Loss on drying | ≤10.0% | ≤15.0% | ||
| Total ash | ≤6.0% | ≤6.0% | |||
| Ash insoluble in hydrochloric acid | ≤1.0% | ||||
| ASSAY | Content | ≥ 0.3 % of total saponins, expressed as platycodin D (C57H92O28; Mr 1225) (dried drug). | ≥0.1% platycodin (C57H92O28; Mr 1225) | ||
| Ethanol-soluble extractive | ≥17.0% | ||||
| 277 | Podophyllum Resin | IDENTIFICATION | Thin-layer chromatography | podophyllotoxin,phenazone. | |
| TESTS | Loss on drying | ≤5.0% | |||
| Sulfated ash | ≤1.0% | ||||
| ASSAY | |||||
| 279 | Polygonum Orientale Fruit | IDENTIFICATION | Microscopic examination | powder | powder |
| Thin-layer chromatography | taxifolin and kaempferol | taxonin | |||
| TESTS | Loss on drying | 12.0% | - | ||
| Total ash | ≤3.0% | ≤5.0% | |||
| ASSAY | Content | ≥ 0.15% of taxifolin (C15H12O7 ; Mr 304.3) (dried drug). | ≥ 0.15% of taxifolin (C15H12O7 ; Mr 304.3) (dried drug). | ||
| 280 | Poria | IDENTIFICATION | Thin-layer chromatography | 4-aminobenzoic acid , coumarin | |
| TESTS | Loss on drying | ≤13.0% | |||
| Total ash | ≤1.0% | ||||
| Foreign matter | ≥0.1% of brown skins and roots of conifer and ≥2 %of other foreign matter. | ||||
| ASSAY | Water-soluble extractive | ≥1.5% | |||
| 281 | Prepared Belladonna | IDENTIFICATION | Thin-layer chromatography | hyoscyamine sulfate | |
| TESTS | Loss on drying | ≤5.0% | |||
| Total ash | ≤16.0% | ||||
| Ash insoluble in hydrochloric acid | ≤4.0% | ||||
| ASSAY | Content | 0.28 to 0.32 % of total alkaloids, expressed as hyoscyamine (Mr 289.4) (dried drug). | |||
| 282 | Prepared Ipecacuanha | IDENTIFICATION | Microscopic examination | powder | |
| Thin-layer chromatography | emetine hydrochloride and cephaeline hydrochloride | ||||
| TESTS | Loss on drying | ≤5.0% | |||
| Total ash | ≤5.0% | ||||
| Ash insoluble in hydrochloric acid | ≤3.0% | ||||
| ASSAY | Content | 1.9 to 2.1 % of total alkaloids, expressed as emetine (C29H40N2O4 ; Mr 480.6) (dried drug). | |||
| 283 | Prepared Opium | IDENTIFICATION | Microscopic examination | powder | |
| Thin-layer chromatography | morphine hydrochloride , papaverine hydrochloride ,codeine phosphate, noscapine hydrochloride | ||||
| TESTS | Loss on drying | ≤8.0% | |||
| Total ash | ≤6.0% | ||||
| Liquid chromatography | Thebaine | ||||
| ASSAY | Content | — morphine (C17H19NO3 ; Mr 285.3): 9.5 per cent to 10.5 per cent (dried preparation); — codeine (C18H21NO3 ; Mr 299.4): minimum 1.0 per cent (dried preparation). | |||
| 284 | Prepared Stramonium | IDENTIFICATION | Microscopic examination | powder | |
| Thin-layer chromatography | hyoscyamine sulfate | ||||
| TESTS | Loss on drying | ≤20.0% | |||
| Total ash | ≤5.0% | ||||
| Ash insoluble in hydrochloric acid | ≤4.0% | ||||
| ASSAY | Content | 0.23 to 0.27 % of total alkaloids, expressed as hyoscyamine (C17H23NO3 ; Mr 289.4) (dried drug). | |||
| 285 | Primula Root | IDENTIFICATION | Microscopic examination | powder | |
| Thin-layer chromatography | anisaldehyde solution | ||||
| TESTS | Loss on drying | ≤10.0% | |||
| Total ash | ≤9.0% | ||||
| Ash insoluble in hydrochloric acid | ≤3.0% | ||||
| ASSAY | |||||
| 286 | Processed Angelica Sinensis Root | IDENTIFICATION | Thin-layer chromatography | (Z)-ligustilide , imperatorin | |
| TESTS | Loss on drying | ≤12.0% | |||
| Total ash | ≤7.0% | ||||
| Ash insoluble in hydrochloric acid | ≤2.0% | ||||
| ASSAY | Content | 0.050 % of trans-ferulic acid (C10H10O4 ; Mr 194.2) (dried drug). | |||
| 287 | Processed Liquorice Root for use in TCM | IDENTIFICATION | Microscopic examination | powder | |
| Thin-layer chromatography | glycyrrhetic acid and thymol | ||||
| TESTS | Loss on drying | ≤10.0% | |||
| Total ash | ≤5.0% | ||||
| Acid-insoluble ash | ≤1.0% | ||||
| Ochratoxin A | ≤20 ppb | ||||
| ASSAY | Content | ≥2.0% of glycyrrhizic acid (C42H62O16) calculated with reference to the dried material. | |||
| 288 | Processed Salvia Miltiorrhiza Rhizome and Root | IDENTIFICATION | Microscopic examination | powder | |
| Thin-layer chromatography | tanshinone IIA , rosmarinic acid and salvianolic acid B | ||||
| TESTS | Loss on drying | ≤12.0% | |||
| Total ash | ≤10.0% | ||||
| Acid-insoluble ash | ≤2.0% | ||||
| ASSAY | Content | ≥ 0.04% of tanshinone IIA (C19H18O3 ), not less than 0.17% of rosmarinic acid (C18H16O8 ) and not less than 3.0% of salvianolic acid B (C36H36O16), calculated with reference to the dried material | |||
| 292 | Pygeum Bark | IDENTIFICATION | Microscopic examination | powder | |
| Thin-layer chromatography | β-sitosterol and ursolic acid | ||||
| TESTS | Loss on drying | ≤12.0% | |||
| Total ash | ≤10.0% | ||||
| Foreign matter | ≤3% | ||||
| ASSAY | Extractable matter | ≥0.5% | |||
| 293 | Quantified St. John’s Wort Dry Extract | IDENTIFICATION | Thin-layer chromatography | hyperoside and utoside trihydrate, chlorogenic acid | hyperoside |
| TESTS | Water | ≤8.5% | ≤12.0% | ||
| ASSAY | Content | — total hypericins, expressed as hypericin (C30H16O8 ; Mr 504.4): 0.10 per cent to 0.30 per cent (anhydrous extract); — flavonoids, expressed as rutoside (C27H30O16; Mr 610.5): minimum 6.0 per cent (anhydrous extract); — hyperforin (C35H52O4 ; Mr 536.8): maximum 6.0 per cent (anhydrous extract) and not more than the content stated on the label. | hyperoside，≥0.1% | ||
| 295 | Quillaia Bark | IDENTIFICATION | Microscopic examination | powder | |
| Thin-layer chromatography | purified quillaia saponins and sucrose | ||||
| TESTS | Loss on drying | ≤10.0% | |||
| Total ash | ≤10.0% | ||||
| Ash insoluble in hydrochloric acid | ≤1.0% | ||||
| ASSAY | Content | ≥ 6.5 %of triterpene glycosides, expressed as quillaia saponin III (C104H168O55; Mr 2298) (dried drug). |